SNHG1 and breast cancer: In line with these findings, Deng et al. [40] demonstrated that SNHG1 downregulation suppressed proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) in breast cancer cells, with miR-641 identified as its target.